02637 HAIXI PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.90X | Oper Margin | 33.5% |
|---|---|---|---|
| LT Debt/Equity | 6.0% | Net Margin | 29.2% |
| Total Debt/Equity | 10.5% | Return on Equity | 25.1% |
| Price/Book | N/A | Return on Assets | 18.0% |
| (HKD 129.100) | 2024-12 | 2023-12 | 2022-12 |
| Net Profit (MHKD) | 144.72 | 129.46 | 77.34 |
|---|---|---|---|
| Net Profit Growth (%) | +11.8 | +67.4 | N/A |
| Earnings Per Share (HKD) | 2.153 | 1.926 | 1.203 |
| Earnings Per Share Growth (%) | +11.8 | +60.1 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend |
| P/E* (X) | 59.95 | 67.02 | 107.28 |
| Yield (%) | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A |
| Book NAV (HKD) | N/A | N/A | N/A |
| Auditors' Opinion | N/A | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-12-15 21:40:20
Latest Result
| (RMBMn) | 2025-05 | 2024-05 | Chg* (%) | |
| Cover Period (mths) | 5 | 5 | NA | |
|---|---|---|---|---|
| Turnover | 249.216 | 180.603 | +38.0 | |
| Operating Result | 103.472 | 71.374 | +45.0 | |
| Profit Before Taxation | 103.466 | 71.374 | +45.0 | |
| Taxation | 13.257 | 8.407 | +57.7 | |
| Profit /( Loss) After Taxation | 90.209 | 62.967 | +43.3 | |
| Net Profit | 90.209 | 62.967 | +43.3 | |
| Earnings Per Share () | 1.4635 | 1.0115 | +44.7 | |
| Announcement Date | 2025-10-09 | 2025-10-09 | NA |
* Annualised
Last Update Time: 2025-12-15 21:40:25
